Vimeo
LinkedIn
Instagram
Share |

pharmaceuticals

January 15, 2016

After working in the pharmaceuticals industry in China, New Zealand, and Spain, 31-year-old Hugo Peris, a fourth-generation member of Spanish family business Laboratorios Salvat, is embarking on his first independent venture. 

After working in the pharmaceuticals industry in China, New Zealand, and Spain, 31-year-old Hugo Peris, a fourth-generation member of Spanish family business Laboratorios Salvat, is embarking on his first independent venture. 

August 19, 2013

British pharmaceutical company leaves founding family’s hands, Carlos Slim launches new satellite, L’Oreal bids for Chinese business, and James Packer has high hopes for his gambling empire’s expansion into Japan.

British pharmaceutical company leaves founding family’s hands, Carlos Slim launches new satellite, L’Oreal bids for Chinese business, and James Packer has high hopes for his gambling empire’s expansion into Japan.

February 27, 2012

Global volatility looks to be taking its toll on European family-run companies Merck and Fiat, which are respectively cutting jobs and considering closing plants to improve margins.

Global volatility looks to be taking its toll on European family-run companies Merck and Fiat, which are respectively cutting jobs and considering closing plants to improve margins.

German family business Merck, which operates in the pharmaceutical industry, plans to reduce its workforce “across all businesses and regions”, according to a statement.

August 30, 2011

Family-controlled Indian conglomerate Piramal Group plans to make a big investment internationally as it seeks growth outside of its home market.

Family-controlled Indian conglomerate Piramal Group plans to make a big investment internationally as it seeks growth outside of its home market.

A spokesman for the company, which operates in a number of areas including pharmaceuticals, real estate and healthcare, told CampdenFB that the Piramal family will invest around $1.5 billion in mostly biotech companies in the US and Europe.

“The investment is part of our ongoing strategic diversification efforts,” he said.

August 22, 2011

The third-generation heir-apparent of India’s Piramal family is set to join the family business, in a move which could help the family to strengthen its succession plans.

The third-generation heir-apparent of India’s Piramal family is set to join the family business, in a move which could help the family to strengthen its succession plans.

Anand Piramal, son of the Piramal Group’s chairman Ajay, is expected to join the group’s real estate arm, according to a report in the Times of India, although it did not reveal when the appointment would happen.

March 25, 2011

Family-controlled pharmaceutical giant Roche said on 25 March that a member of the family shareholding group has dropped out of the pool, causing the family to lose its voting majority.

Family-controlled pharmaceutical giant Roche said on 25 March that a member of the family shareholding group has dropped out of the pool, causing the family to lose its voting majority.

The Basel, Switzerland-based company said in a statement that family member Maja Oeri, who has 5% voting rights, dropped out of the group – called the voting pool – reducing the family pool’s voting power to 45% from 50%.

February 16, 2010

Solvay, the family-controlled international chemical group, has announced it has finalised the sale of its pharmaceutical business to Abbot for €5.2 billion.

Solvay, the family-controlled international chemical group, has announced it has finalised the sale of its pharmaceutical business to Abbot for €5.2 billion. On the back of antitrust clearances, the Belgium-based company also said it planned to buy back up to 5.1 million of the company's own shares.

September 28, 2009

Family-controlled Solvay Group announced today it is to sell its pharmaceutical business to American healthcare company Abbott in a deal worth around €5.2 billion.

Family-controlled Solvay Group announced today it is to sell its pharmaceutical business to American healthcare company Abbott in a deal worth around €5.2 billion.
 
The announcement brings to an end a week of speculation over who the winning bidder would be for the billion-dollar arm of the family company. Abbott will pay €4.5 billion in cash to be made between 2011 and 2013, with additional potential payments of up to €300 million. Abbott will also take on liabilities thought to be worth €400 million.
 

April 29, 2008

Haniel – the family-owned diversified German group – has announced a new strategy that is to focus on trading and services.

Haniel – the family-owned diversified German group – has announced a new strategy that is to focus on trading and services. The group is currently active across a wide range of industries from Europe's leading drugs wholesaler to the recycling of raw materials for the steel industry. However, the group's production sector looks set to be jettisoned.

Click here >>
Close